Celligenics

30/09/2021

Celligenics was invited on CNA’s CNA938, Singapore’s dedicated radio station for news and information, to talk about our collaboration with the Skin Research Institute of Singapore (SRIS) on the Health Matters programme with Daniel Martin.

Join Kurt Wee, CEO of Celligenics, and Dr. Ng Yi Zhen, Programme Co-Lead for the Wound Care Innovation for the Tropics Programme at SRIS, to learn about our new therapy for chronic wounds.

We are grateful to CNA938 and Daniel Martin for taking an interest in our collaboration, and for featuring us on Health Matters.

Read More Here: https://www.facebook.com/CNA938/videos/1174664219727362/

21/09/2021

Celligenics is pleased to announce that we have signed a memorandum of understanding with West China Hospital (Hua Xi) of Sichuan University at the 22nd Singapore-Sichuan Trade and Investment Committee (SSTIC) Meeting.

We are also pleased to announce that we have selected Chengdu as our headquarters in China, and will be developing an Advanced Therapeutics Development Centre in the Chengdu Hi-Tech Industrial Development Zone.

We would like to thank Enterprise Singapore (ESG) and MP Dr. Tan See Leng for recognising our endeavour to build a resilient and competitive global company.

Read More Here: https://www.enterprisesg.gov.sg/media-centre/media-releases/2021/september/mr06621_singapore-and-sichuan-deepen-collaboration-in-trade-and-connectivity-and-innovation

Celligenics is pleased to announce that we have signed a memorandum of understanding with West China Hospital (Hua Xi) of Sichuan University at the 22nd Singapore-Sichuan Trade and Investment Committee Meeting. We are also pleased to announce that we have selected Chengdu as our headquarters in Chin...

09/09/2021

Celligenics is pleased to announce that we have signed a research collaboration agreement with local research institutes, Nanyang Technological University, Singapore's (NTU Singapore) NTU Lee Kong Chian School of Medicine (LKCMedicine) and the Skin Research Institute of Singapore(SRIS), under the Skin Innovation Grant (SIG).

This collaboration will be our staging point towards developing a therapy that accelerates healing in chronic wounds such as diabetic foot ulcers and bed sores. With our joint expertise, preliminary studies have shown outstanding results.

With the support of local partners like NTU Singapore and SRIS, we are thrilled to be pioneers in bringing accessible and affordable therapies for chronic wounds to the market.

Read More Here: https://www.ntu.edu.sg/news/detail/developing-therapies-that-stimulate-healing-in-chronic-wounds

28/03/2021

Thank u Changi General Hospital (CGH) doctors, nurses and staff for hosting Celligenics and at your world-class woundcare treatment facilities. And for sharing your insights and experiences in caring for patients with chronic wounds. We L♥️VE your “Kampung Spirit”!! 🥰🙏🏻

06/02/2021

It was indeed an honour for to be part of a dialogue session yesterday with Dr Tan See Leng, Minister in the Prime Minister’s Office, Second Minister for Trade and Industry and Second Minister for Manpower, organised by the Agency for Science, Technology and Research (A*STAR) and .
Singapore is increasingly recognised as a global epicenter for biotech/therapeutics excellence, and Celligenics is proud to be part of it. We look forward to more public-private partnerships to continuously contribute to our vibrant biotech/therapeutics ecosystem.

08/12/2020

Its here! SWITCH2020 and its different! 7 - 11 December 2020. Come visit us and explore and experience. Come find us at A*Star Village > A*Star Incubates > Exhibition > Celligenics

08/12/2020

Come join us at SWITCH 2020! A first for Digital exhibition. Visit us digitally and speak with us. Get your tickets at https://www.switchsg.org/register-now

20/04/2020

We are proud to have our Chief Operating Officer, Dr. Pauline Erica Tay, featured in the March issue of Portfolio Magazine's Profile of the Month, celebrating the strong contributions & achievements of Women in STEM.

Our March cover profile is stem cell researcher and Celligenics COO Pauline Erica Tay, who is building the ecosystem that propels Singapore’s biomedical industry onto the international stage.

24/01/2020

Wishing all a prosperous New Year from all of us at Celligenics!

13/01/2020

Got our dream team together on a Corporate Workplan Retreat to share our vision for the next chapter of our business's growth. Looking forward to the rest of 2020!